Contributor:

Robert Avery MD, PhD

Track the History–and Future–of Anti-VEGF

Robert Avery, MD; Timothy G. Murray, MD

RGX-314 for Wet AMD

Robert Avery MD, PhD

Advances in Retinal Drug Delivery

Robert L. Avery, MD, Timothy G. Murray, MD, MBA

Growing Comfortable with the Suprachoroidal Space

Maria Berrocal, MD, and Robert L. Avery, MD

Implementing AI in Retina

Robert L. Avery, MD, interviewed by R.V. Paul Chan, MD, MSc, MBA

Celebrating the 30th Anniversary of LASIK

Eric D. Donnenfeld, MD, Marguerite McDonald, MD, FACS, Robert K. Maloney, MD

Balancing Interests and Integrity

Robert J. Weinstock, MD, Sumitra Khandelwal, MD

Updates With Rho Kinase

Jason Bacharach, MD, Robert Weinstock, MD

Extending Treatment Efficacy in Wet AMD

Lejla Vajzovic, MD; Robert L. Avery, MD; Carl D. Regillo, MD; and Durga S. Borkar, MD, MMCi

Tackling PVR in the OR

Allen C. Ho, MD; Robert L. Avery, MD; Dean Eliott, MD; Avni P. Finn, MD, MBA; Ajay Kuriyan, MD, MS; and M. Ali Khan, MD

Treating GA In Your Clinic

Allen C. Ho, MD; Robert L. Avery, MD; Eleonora M. Lad, MD, PhD; Jeffrey S. Heier, MD; and Dilsher Dhoot, MD

The Era of Geographic Atrophy Treatment Begins

Allen C. Ho, MD; and Robert L. Avery, MD

Advances in Gene Therapy for Wet AMD

Allen C. Ho, MD; Robert L. Avery, MD; Peter Campochiaro, MD, PhD; Jeffrey S. Heier, MD; Szilárd Kiss, MD; and Charles Wykoff, MD, PhD